Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × Dexmedetomidine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 17 Breast Neoplasms 12 Brain Neoplasms 11 Agnosia 7 Neoplasms 6 Lung Neoplasms 5 Delirium 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Pituitary Neoplasms 3 Pain 3 Emergence Delirium 3 Colorectal Neoplasms 3 Chronic Pain 3 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Inflammation 2 Dexmedetomidine 2 Colonic Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Urinary Bladder Neoplasms 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1

Interventions

Magnetic Resonance Spectroscopy 12 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 Bevacizumab 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Sodium Chloride 3 Ga(III)-DOTATOC 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 vistusertib 2 trametinib 2 ribociclib 2 arginyllysine 2 aldesleukin 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Saline Solution 2 Ropivacaine 2 Radiotherapy 2 Protons 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡